推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Infectious Diseases and Therapy

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 最新评论:暂无评论!


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Infectious Diseases and Therapy期刊基本信息Hello,您是该期刊的第18540位访客

基本信息 登录收藏
期刊名字Infectious Diseases and TherapyInfectious Diseases and Therapy

INFECT DIS THER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.9
50人评分
我要评分

声誉
8.3

影响力
5.8

速度
7.0

期刊ISSN2193-8229
微信扫码收藏此期刊
E-ISSN2193-6382
2023-2024最新影响因子
(数据来源于搜索引擎)
4.7 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:3.777
2023-2024自引率4.30%点击查看自引率趋势图
五年影响因子4.6
JCI期刊引文指标 0.93
h-index 暂无h-index数据
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
8.601.3511.311
学科分区排名百分位
大类:Medicine
小类:Infectious Diseases
Q161 / 344
大类:Medicine
小类:Microbiology (medical)
Q131 / 140

期刊简介
Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.
期刊官方网站https://www.springer.com/40121
期刊投稿网址https://www.editorialmanager.com/inth
作者指南网址https://www.springer.com/40121/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Infectious Diseases and Therapy的语言要求,还能让Infectious Diseases and Therapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Infectious Diseases and Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP4700; USD6850; EUR5500; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:pharmacoeconomics、public health、infectious diseases、epidemiology
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式236 GRAYS INN RD, 6TH FLOOR, LONDON, ENGLAND, WC1X 8HL
出版商Springer Healthcare
涉及的研究方向Medicine-Microbiology (medical)
出版国家或地区ENGLAND
出版语言English
出版周期6 issues per year
出版年份2012
年文章数 144点击查看年文章数趋势图
Gold OA文章占比98.50%
研究类文章占比:
文章 ÷(文章 + 综述)
77.78%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:INFECTIOUS DISEASESSCIEQ120/132
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:INFECTIOUS DISEASESSCIEQ132/132
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区3区3区
INFECTIOUS DISEASES
传染病学
2区1区3区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区3区3区
INFECTIOUS DISEASES
传染病学
3区2区3区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区3区2区
INFECTIOUS DISEASES
传染病学
2区2区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2193-8229%5BISSN%5D
平均审稿速度网友分享经验:
6 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( GBP4700; USD6850; EUR5500; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Infectious Diseases and Therapy顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Infectious Diseases and Therapy期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Infectious Diseases and Therapy中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Infectious Diseases and Therapy上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Gut Microbes018.20
    Journal of Fungi06.70
    Microorganisms07.40
    Microbial Risk Analysis05.70
    Mikrobiolohichnyi Zhurnal00.70
    Interdisciplinary Perspectives on Infectious Diseases04.10
    Acta Microbiologica Hellenica00.20
    Access Microbiology02.00
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677320
    BIOMATERIALS567016
    BIOMEDICINE & PHARMACOTHERAPY551721
    Frontiers in Pharmacology515525
    Journal of Materials Chemistry B506403
    Frontiers in Immunology492230
    COMPUTERS IN BIOLOGY AND MEDICINE474054
    JOURNAL OF ETHNOPHARMACOLOGY466427
    COLLOIDS AND SURFACES B-BIOINTERFACES438646
    Frontiers in Oncology436282
  •  

    Infectious Diseases and Therapy Infectious Diseases and Therapy
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study

    Author: Xu, Wei; Hu, Qiankun; Chen, Chong; Li, Weixia; Li, Qiang; Chen, Liang
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 487-498. DOI: 10.1007/s40121-022-00738-1
        PubMed      DOI
    2.Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019

    Author: Li, Meng; Yang, Shanshan; Yao, Hongwu; Liu, Yunxi; Du, Mingmei
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 473-485. DOI: 10.1007/s40121-022-00732-7
        PubMed      DOI
    3.Association Between Lactate and 28-Day Mortality in Elderly Patients with Sepsis: Results from MIMIC-IV Database

    Author: He, Liudang; Yang, Donghua; Ding, Qiong; Su, Yingjie; Ding, Ning
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 459-472. DOI: 10.1007/s40121-022-00736-3
        PubMed      DOI
    4.Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19

    Author: Meng, Qing; Li, Wujiao; Jiang, Hanfang; Yan, Huimin; Wang, Heping; Ye, Binjun; Zhou, Lintao; Chen, Yunsheng
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 563-575. DOI: 10.1007/s40121-022-00751-4
        PubMed      DOI
    5.The Association Between Alveolar-Arterial Oxygen Tension Difference and the Severity of COVID-19 in Patients

    Author: Xie, Canbin; Deng, Jiayi; Li, Fanglin; Wu, Chenfang; Xu, Min; Yu, Bo; Wu, Guobao; Zhong, Yanjun; Tang, Da; Li, Jinxiu
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 577-587. DOI: 10.1007/s40121-022-00752-3
        PubMed      DOI
    6.Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study

    Author: Hu, Meixin; Liao, Guichan; Wei, Sufang; Qian, Zhe; Chen, Hongjie; Xia, Muye; Xie, Qiuli; Peng, Jie
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 637-647. DOI: 10.1007/s40121-022-00757-y
        PubMed      DOI
    7.Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients

    Author: Weng, Chengzhao; Xie, Rongcheng; Han, Guanjie; Yuan, Ya; Li, Shiqin; Wang, Chao; Wang, Xiaofeng; Jiang, Wei; Jiang, Libo
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 649-662. DOI: 10.1007/s40121-023-00760-x
        PubMed      DOI
    8.Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

    Author: Chen, Guiling; Li, Nan; Dai, Xiahong; Tu, Shiyan; Shen, Zhenwei; Wu, Kaiqi; Jin, Tinghan; Wu, Jiajun; Peng, Conggao; Sheng, Guoping; Zhu, Mengfei; Tang, Lingling; Li, Lanjuan
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 663-675. DOI: 10.1007/s40121-023-00759-4
        PubMed      DOI
    9.Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study

    Author: Huang, Shuai-Wen; Li, Xi-Tang; Chen, Chen; Ning, Qin; Huang, Jia-Quan
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 3, pp. 871-890. DOI: 10.1007/s40121-023-00766-5
        PubMed      DOI
    10.Risk Factors for Melioidosis Mortality and Epidemics: A Multicentre, 10-Year Retrospective Cohort Study in Northern Hainan

    Author: Zheng, Wanting; Kuang, Shicheng; Zhong, Chengwang; Zhou, Jing; Long, Wenfang; Xiao, Sha; Wu, Biao
    Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 3, pp. 951-964. DOI: 10.1007/s40121-023-00768-3
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Computational Visual Media016.90
    Industrial and Organizational Psychology-Perspectives on Science and Practice07.70
    COMMUNICATIONS OF THE ACM18916.10
    MedComm06.70
    Journal of Econometrics1358.60
    CLINICAL NUCLEAR MEDICINE532.90
    Journal of International Financial Management & Accounting09.10
    BMJ Evidence-Based Medicine08.90
    ARCHIVOS DE BRONCONEUMOLOGIA413.50
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共0


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室